Isabelle Rouquette

Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

Fabrice Barlési, Julien Mazières, Jean‐Philippe Merlio et al. · The Lancet · 2016 · 969 citations · Full text

Advanced Lung Disease, Medicine, Pathology +8

Lung Cancer That Harbors an <i>HER2</i> Mutation: Epidemiologic Characteristics and Therapeutic Perspectives

Julien Mazières, Solange Peters, Benoît Lepage et al. · Journal of Clinical Oncology · 2013 · 651 citations

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network

Michèle Beau‐Faller, Nathalie Prim, Anne-Marie Ruppert et al. · Annals of Oncology · 2013 · 312 citations · Full text

Rare Egfr, Non-small-cell Lung Cancer, Medicine +8

PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab

Nicolas Guibert, Myriam Delaunay, Amélie Lusque et al. · Lung Cancer · 2018 · 225 citations

Cancer Immunosurveillance, Pd-l1 Expression, Medicine +8

Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer

Julien Adam, Nolwenn Le Stang, Isabelle Rouquette et al. · Annals of Oncology · 2018 · 211 citations · Full text